Table 2.
MBZ group | QC group | |
n = 61 | n = 61 | |
Cure rate | 48 (78.7%) | 51 (83.6%) |
Any adverse event | 14 (22.9%) | 36 (59%) |
Abdominal pain | 11 (18 %) | 10 (16.3%) |
Vomiting | 3 (4.9%) | 14 (22.9%) |
Nausea | 3 (4.9%) | 14 (22.9%) |
Headache | 1 (1.6%) | 11 (18%) |
Yellowish coloration of the skin | - | 15 (24.6%) |